Efficacy News and Research

RSS

UC Davis Health tests new antibody combination as potential treatment for COVID-19

Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.

From The University of California, Davis 21 Jul 2020

Simple blood test could advance life-saving treatment for heart failure

Biomedical experts believe that half of heart failure patients likely have low levels of the thyroid hormone T3 in their cardiac tissue.

20 Jul 2020

Using blood samples to detect positive COVID-19 cases in 20 minutes

World-first research by Monash University in Australia has been able to detect positive COVID-19 cases using blood samples in about 20 minutes, and identify whether someone has contracted the virus.

20 Jul 2020

A new approach to combat drug resistance in aggressive age-related macular degeneration

An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), an aggressive form of age-related macular degeneration, the leading cause of irreversible blindness in the elderly.

17 Jul 2020

Beautyberry leaf extract boosts drug's activity antibiotic-resistant staph bacteria

Scientists discovered a compound in the leaves of a common shrub, the American beautyberry, that boosts an antibiotic's activity against antibiotic-resistant staph bacteria. Laboratory experiments showed that the plant compound works in combination with oxacillin to knock down the resistance to the drug of methicillin-resistant Staphylococcus aureus, or MRSA.

17 Jul 2020

Study shows genetic factors may influence the susceptibility to COVID-19

A new Cleveland Clinic study has identified genetic factors that may influence susceptibility to COVID-19. Published today in BMC Medicine, the study findings could guide personalized treatment for COVID-19.

16 Jul 2020

Umbilical cord blood treats children born with non-cancerous genetic disorders

Researchers at UPMC Children's Hospital of Pittsburgh found that infusing umbilical cord blood -- a readily available source of stem cells -- safely and effectively treated 44 children born with various non-cancerous genetic disorders, including sickle cell, thalassemia, Hunter syndrome, Krabbe disease, metachromatic leukodystrophy (MLD) and an array of immune deficiencies.

15 Jul 2020

Investigational COVID-19 vaccine is safe, generates neutralizing antibody activity in healthy adults

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.

15 Jul 2020

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

15 Jul 2020

New radiopharmaceutical offers precise diagnosis and treatment of prostate cancer in preclinical studies

Researchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis and treatment of prostate cancer in preclinical studies.

14 Jul 2020

Novel approach to analyze organ development through gene analysis in single cells

When cells develop, variations in the interaction of genes of an individual determine their fate. Such variations in genetic interactions can make the individual’s cells powerful against infection from viruses or enable the immune cells to kill the tumor cells.

14 Jul 2020

PET radiotracer is safe and effective for imaging malignant brain tumors

A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.

14 Jul 2020

New radiotracer provides a quantitative measure of disease progression after stroke

A new radiotracer, 18F-SynVesT-2, can directly assess synaptic density changes in the brain, providing an objective and quantitative measure of disease progression after stroke.

14 Jul 2020

UTEP receives $1.3 million to shed light on how neural circuits impact specific behaviors in humans

The University of Texas at El Paso was awarded $1.3 million from the National Institutes of Health to shed light on how the combined function of neural circuits impacts specific behaviors in humans.

14 Jul 2020

Researchers explore the reproduction of adenoviruses in cells

An adenovirus infection can be potentially life-threatening, especially for children after a stem cell transplant.

14 Jul 2020

Severely injured donor lungs can be recovered using cross-circulation platform

Respiratory disease is the third leading cause of death worldwide, and lung transplantation is still the only cure for patients with end-stage lung disease.

14 Jul 2020

Researchers use DSC-based method to measure protein-ligand binding

A team of researchers from Kazan Federal University, Russia, led by Dr. Igor Sedov, reported an application of capillary differential scanning calorimetry technique for the study of the binding of albumin, a plasma transport protein, with different drug ligands.

14 Jul 2020

Efficacy News and Research

UC Davis Health tests new antibody combination as potential treatment for COVID-19

Simple blood test could advance life-saving treatment for heart failure

Using blood samples to detect positive COVID-19 cases in 20 minutes

A new approach to combat drug resistance in aggressive age-related macular degeneration

Beautyberry leaf extract boosts drug's activity antibiotic-resistant staph bacteria

Study shows genetic factors may influence the susceptibility to COVID-19

Umbilical cord blood treats children born with non-cancerous genetic disorders

Investigational COVID-19 vaccine is safe, generates neutralizing antibody activity in healthy adults

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

New radiopharmaceutical offers precise diagnosis and treatment of prostate cancer in preclinical studies

Novel approach to analyze organ development through gene analysis in single cells

PET radiotracer is safe and effective for imaging malignant brain tumors

New radiotracer provides a quantitative measure of disease progression after stroke

UTEP receives $1.3 million to shed light on how neural circuits impact specific behaviors in humans

Researchers explore the reproduction of adenoviruses in cells

Severely injured donor lungs can be recovered using cross-circulation platform

Researchers use DSC-based method to measure protein-ligand binding

New technology generates immune response by delivering antigens to APCs in the spleen

DNA repair tool is tailored to deal with specific type of complex break, study shows

Engineered T-cells attack solid-tumor cancer cells from humans and mice

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics